Used in the synthesis of β-blockers, particularly in the production of chiral intermediates for pharmaceuticals. Its structure supports the development of cardioselective agents targeting hypertension and arrhythmias. The chiral center allows for selective interaction with adrenergic receptors, improving drug efficacy and reducing side effects. Commonly employed in asymmetric synthesis routes where the hydroxy and amino functional groups are further modified to form active drug substances.